EUVIMEDEUVIMED entdecken
Crossref

Association between Thromboembolic Events and the JAK2 V617F Mutation in Myeloproliferative Neoplasms

Yuka Takata, Ritsuko Seki, Taisuke Kanajii, Masayuki Nohara, Satoko Koteda, Kuniki Kawaguchi, Kei Nomura, Takayuki Nakamura, Satoshi Morishige, Eijirou Oku, Koichi Osaki, Emichitoshi Hashiguchi und 4 weitere

The Kurume Medical Journal · 31.01.2014 · 60 (3.4) · 89-97

DOI: 10.2739/kurumemedj.ms63001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kurume Medical Journal, erschienen am 31.01.2014. Verfasst von Yuka Takata und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Kurume University School of Medicine. Hauptthemen laut MEDLINE: Mutation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombotic complications are a major cause of death in patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), which are closely associated with the JAK2 V617F activating mutation. However, whether the presence of the JAK2 V617F mutation affects thrombotic risk is currently unknown, although some reports have suggested a variable association with thrombosis. Therefore, we investigated the association between JAK2 V617F and various complications, including thrombosis, in Japanese patients with MPNs. We assessed the JAK2 V617F status in 140 patients who were diagnosed or doubted as having some type of MPN by utilizing a JAK2 V617F-specific guanine-quenching probe. JAK2 V617F was detected in 31 of 51 patients (60.8%) with essential thrombocythemia, all 16 patients (100%) with polycythemia vera, 4 of 11 patients (36.4%) with primary myelofibrosis, 2 of 18 patients (11.1%) with other types of MPNs, and none of the 44 patients with doubted MPN. In the 78 patients with classical MPN, JAK2 V617F correlated with a leukocyte count ≥10,000/μl (p=0.046). Complications of thrombosis, hemorrhage, and leukemic transformation occurred in 21 (41.2%), 4 (25.0%), and 3 (27.3%) patients with classical MPN, respectively, and thrombotic events (TE) occurred more frequently in patients with JAK2 V617F than without (p=0.047). Based on these findings, initial screening for the JAK2 mutation and careful monitoring for thrombotic events should be performed in patients with MPN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationAdolescentAdultAgedAged, 80 and overChildDNA Mutational AnalysisFemaleGenetic Predisposition to DiseaseGenetic TestingHumansIncidenceJanus Kinase 2JapanLeukocyte CountMaleMiddle AgedMyeloproliferative DisordersPolycythemia VeraPredictive Value of TestsPrimary Myelofibrosis

Substanzen

JAK2 protein, humanJanus Kinase 2

Autor:innen und Institutionen

  • Department of Medicine, Kurume University School of Medicine.

Zitieren

APA

Takata, Y., Seki, R., Kanajii, T., Nohara, M., Koteda, S., Kawaguchi, K., Nomura, K., Nakamura, T., Morishige, S., Oku, E., Osaki, K., Hashiguchi, E., Mouri, F., Yoshimoto, K., Nagafuji, K., & Okamura, T. (2014). Association between Thromboembolic Events and the JAK2 V617F Mutation in Myeloproliferative Neoplasms. The Kurume Medical Journal, 60(3.4), 89-97. https://doi.org/10.2739/kurumemedj.ms63001

Vancouver

Takata Y, Seki R, Kanajii T, Nohara M, Koteda S, Kawaguchi K, et al. Association between Thromboembolic Events and the JAK2 V617F Mutation in Myeloproliferative Neoplasms. The Kurume Medical Journal. 2014;60(3.4):89-97. doi:10.2739/kurumemedj.ms63001

BibTeX
@article{Takata2014,
  author = {Takata, Yuka and Seki, Ritsuko and Kanajii, Taisuke and Nohara, Masayuki and Koteda, Satoko and Kawaguchi, Kuniki and Nomura, Kei and Nakamura, Takayuki and Morishige, Satoshi and Oku, Eijirou and Osaki, Koichi and Hashiguchi, Emichitoshi and Mouri, Fumihiko and Yoshimoto, Koji and Nagafuji, Koji and Okamura, Takashi},
  title = {Association between Thromboembolic Events and the JAK2 V617F Mutation in Myeloproliferative Neoplasms},
  journal = {The Kurume Medical Journal},
  year = {2014},
  volume = {60},
  number = {3.4},
  pages = {89--97},
  doi = {10.2739/kurumemedj.ms63001}
}
Kostenlos starten →